Scarica l'app Stockscreener
25.81
1.17%
0.2923
Precedente Chiudi:
$25.52
Aprire:
$25.66
Volume 24 ore:
2.85M
Relative Volume:
0.50
Capitalizzazione di mercato:
$12.89B
Reddito:
$4.89B
Utile/perdita netta:
$-242.00M
Rapporto P/E:
-52.79
EPS:
-0.489
Flusso di cassa netto:
$315.00M
1 W Prestazione:
+1.89%
1M Prestazione:
+4.36%
6M Prestazione:
+6.69%
1 anno Prestazione:
+79.42%
Intervallo 1D:
$25.39
$26.07
Intervallo di 1 settimana:
$24.59
$26.07
Portata 52W:
$13.39
$27.72
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
25.80 | 12.69B | 4.89B | -242.00M | 315.00M | -0.489 |
TAK
Takeda Pharmaceutical Co Adr
|
17.73 | 55.69B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
10.24 | 43.77B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.88 | 36.19B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.82 | 32.25B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
521.14 | 26.29B | 3.17B | 1.29B | 1.01B | 27.09 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Buy |
| 2026-01-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Aggiornamento | Argus | Hold → Buy |
| 2025-10-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Elanco Animal Health Inc (ELAN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Elanco Animal Health Inc (ELAN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says - Moomoo
Castleark Management LLC Raises Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Inc (ELAN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Elanco Animal Health Inc (ELAN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Did New Tick-Data Edge for Credelio Quattro Just Shift Elanco Animal Health's (ELAN) Investment Narrative? - Yahoo Finance
Elanco (ELAN) Stock Looks Below Fair Value While A 108% Return Tests Upside - Yahoo Finance
Elanco Animal Health Inc (ELAN) Cash Flow - TradingKey
Elanco Animal Health Inc (ELAN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Elanco Animal Health Incorporated Revenue Breakdown – NYSE:ELAN - TradingView
ELAN4667244 Bond Profile — Key Metrics - TradingView
Elanco Animal Health Incorporated $ELAN Shares Purchased by Sei Investments Co. - MarketBeat
Elanco Animal Health Incorporated (ELAN) stock price, news, quote and history - Yahoo Finance UK
Elanco Animal Health Inc (ELAN) Institutional Confidence - TradingKey
Rising parasite threats put pets and livestock at risk as tick levels surge nationwide - KOKH
Elanco Animal Health Incorporated (ELAN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Credelio Quattro™ Kills Ticks(1) Faster(2) Than Simparica Trio® and NexGard® Plus - CSRwire
Elanco Animal Health Price Target Raised to $26.00/Share From $23.00 by Morgan Stanley - Moomoo
ELAN Maintained by Morgan Stanley -- Price Target Raised to $26. - GuruFocus
Morgan Stanley Issues Positive Forecast for Elanco Animal Health (NYSE:ELAN) Stock Price - MarketBeat
Are You Looking for a Top Momentum Pick? Why Elanco Animal Health Incorporated (ELAN) is a Great Choice - Yahoo Finance
Elanco Animal Health Incorporated Stock 12‑Month Price Target Raised to $30.23, Implies 19% Upside - TradingView
Elanco’s Credelio Quattro shows faster tick kill in study By Investing.com - Investing.com Canada
Elanco's Credelio Quattro Maintains 8-Hour Tick Kill Through Day 28 - Stock Titan
Elanco Animal Health Incorporated $ELAN Shares Sold by Bank of New York Mellon Corp - MarketBeat
Dimensional Fund Advisors LP Has $586.92 Million Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
LLY4841184 Bond Profile — Key Metrics - TradingView
Jennison Associates LLC Purchases 494,216 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Principal Financial Group Inc. Grows Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
472,814 Shares in Elanco Animal Health Incorporated $ELAN Purchased by Dorsey Wright & Associates - MarketBeat
Allspring Global Investments Holdings LLC Acquires New Shares in Elanco Animal Health Incorporated $ELAN - MarketBeat
KIN stock trades quietly as Kindred Biosciences acquisition leaves legacy metrics in focus - ad-hoc-news.de
Geneos Wealth Management Inc. Purchases 196,884 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Fifth Third Bancorp Grows Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Ends Apollo Government Relations Lobbying Deal - Legis1
Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
ECO Animal Health delivers stronger than expected results as vaccine strategy gains momentum (EAH) - Yahoo Finance UK
Elanco Animal Health (NYSE: ELAN) awards CEO new deferred stock units - Stock Titan
Elanco Animal Health (NYSE: ELAN) awards CFO new deferred stock units - Stock Titan
Elanco Animal Health (NYSE: ELAN) awards deferred stock units to company officer - Stock Titan
Dimensional Fund Advisors reports 5.1% Elanco Animal Health (ELAN) stake - Stock Titan
Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
How Elanco Helped Puppies Fight Parvo - CSRwire
Form 4 Elanco Animal Health For: 9 July By Investing.com - Investing.com Nigeria
Elanco (NYSE: ELAN) CFO uses 15,336 shares to cover tax liability - Stock Titan
Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement - GuruFocus
Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health - AOL.com
Integrated Advisors Network LLC Purchases New Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Strs Ohio Grows Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
SG Americas Securities LLC Reduces Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.44%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):